François-Clément Bidard, Head, Center of Clinical Investigation CIC-2501 at Inserm, shared on LinkedIn:
“‘Precision Treatment Sequencing in mBC’, an ESMO Advanced Course for Asia-Pacific: a bit of NGS, a lot of ctDNA, a bit of ADC sequencing, S6, S6 and S6, some brain mets management, mBC subtypes, current tt algorithms… and how to adopt (adapt?) all this across APAC.
Thanks for having me in Singapore․
Chairs։ Tira Tan and Evandro de Azambuja
Faculty: Philippe Aftimos, Giampaolo Bianchini, Rebecca Dent, Ravindran Kanesvaran, Samuel Ow, Janice Tsang, Yoon-Sim Yap, Paola Zagami.”
To which Philippe Aftimos, Director of the Innovative Therapies Clinic at Institut Jules Bordet, added:
“Fantastic program and stellar faculty!
My take home message: precision medicine is the cornerstone of second-line therapy for ER+/HER2- metastatic breast cancer.”
Other articles about breast cancer on OncoDaily.